img

Global Antipsychotic Medications Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antipsychotic Medications Market Insights, Forecast to 2034

Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions.
The global Antipsychotic Medications market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antipsychotic Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Antipsychotic Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Antipsychotic Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Antipsychotic Medications include Johnson and Johnson, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer and GlaxoSmithKline, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Antipsychotic Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Antipsychotic Medications, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antipsychotic Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antipsychotic Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Antipsychotic Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Antipsychotic Medications sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson and Johnson, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer and GlaxoSmithKline, etc.



By Company


Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Segment by Type
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Tricyclic Antidepressants (TCAs)
Monoamine Oxidase Inhibitors (MAOIs)
Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
Tetracyclic Antidepressants (TeCAs)
Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)

Segment by Application


Hospital Pharmacies
Drug Stores
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Antipsychotic Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Antipsychotic Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antipsychotic Medications sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Antipsychotic Medications Product Introduction
1.2 Market by Type
1.2.1 Global Antipsychotic Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Selective Serotonin Reuptake Inhibitors (SSRIs)
1.2.3 Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
1.2.4 Tricyclic Antidepressants (TCAs)
1.2.5 Monoamine Oxidase Inhibitors (MAOIs)
1.2.6 Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
1.2.7 Tetracyclic Antidepressants (TeCAs)
1.2.8 Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
1.3 Market by Application
1.3.1 Global Antipsychotic Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antipsychotic Medications Sales Estimates and Forecasts 2018-2034
2.2 Global Antipsychotic Medications Revenue by Region
2.2.1 Global Antipsychotic Medications Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Antipsychotic Medications Revenue by Region (2018-2024)
2.2.3 Global Antipsychotic Medications Revenue by Region (2024-2034)
2.2.4 Global Antipsychotic Medications Revenue Market Share by Region (2018-2034)
2.3 Global Antipsychotic Medications Sales Estimates and Forecasts 2018-2034
2.4 Global Antipsychotic Medications Sales by Region
2.4.1 Global Antipsychotic Medications Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Antipsychotic Medications Sales by Region (2018-2024)
2.4.3 Global Antipsychotic Medications Sales by Region (2024-2034)
2.4.4 Global Antipsychotic Medications Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antipsychotic Medications Sales by Manufacturers
3.1.1 Global Antipsychotic Medications Sales by Manufacturers (2018-2024)
3.1.2 Global Antipsychotic Medications Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antipsychotic Medications in 2022
3.2 Global Antipsychotic Medications Revenue by Manufacturers
3.2.1 Global Antipsychotic Medications Revenue by Manufacturers (2018-2024)
3.2.2 Global Antipsychotic Medications Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antipsychotic Medications Revenue in 2022
3.3 Global Key Players of Antipsychotic Medications, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Antipsychotic Medications Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antipsychotic Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antipsychotic Medications, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antipsychotic Medications, Product Offered and Application
3.8 Global Key Manufacturers of Antipsychotic Medications, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antipsychotic Medications Sales by Type
4.1.1 Global Antipsychotic Medications Historical Sales by Type (2018-2024)
4.1.2 Global Antipsychotic Medications Forecasted Sales by Type (2024-2034)
4.1.3 Global Antipsychotic Medications Sales Market Share by Type (2018-2034)
4.2 Global Antipsychotic Medications Revenue by Type
4.2.1 Global Antipsychotic Medications Historical Revenue by Type (2018-2024)
4.2.2 Global Antipsychotic Medications Forecasted Revenue by Type (2024-2034)
4.2.3 Global Antipsychotic Medications Revenue Market Share by Type (2018-2034)
4.3 Global Antipsychotic Medications Price by Type
4.3.1 Global Antipsychotic Medications Price by Type (2018-2024)
4.3.2 Global Antipsychotic Medications Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Antipsychotic Medications Sales by Application
5.1.1 Global Antipsychotic Medications Historical Sales by Application (2018-2024)
5.1.2 Global Antipsychotic Medications Forecasted Sales by Application (2024-2034)
5.1.3 Global Antipsychotic Medications Sales Market Share by Application (2018-2034)
5.2 Global Antipsychotic Medications Revenue by Application
5.2.1 Global Antipsychotic Medications Historical Revenue by Application (2018-2024)
5.2.2 Global Antipsychotic Medications Forecasted Revenue by Application (2024-2034)
5.2.3 Global Antipsychotic Medications Revenue Market Share by Application (2018-2034)
5.3 Global Antipsychotic Medications Price by Application
5.3.1 Global Antipsychotic Medications Price by Application (2018-2024)
5.3.2 Global Antipsychotic Medications Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Antipsychotic Medications Market Size by Type
6.1.1 US & Canada Antipsychotic Medications Sales by Type (2018-2034)
6.1.2 US & Canada Antipsychotic Medications Revenue by Type (2018-2034)
6.2 US & Canada Antipsychotic Medications Market Size by Application
6.2.1 US & Canada Antipsychotic Medications Sales by Application (2018-2034)
6.2.2 US & Canada Antipsychotic Medications Revenue by Application (2018-2034)
6.3 US & Canada Antipsychotic Medications Market Size by Country
6.3.1 US & Canada Antipsychotic Medications Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Antipsychotic Medications Sales by Country (2018-2034)
6.3.3 US & Canada Antipsychotic Medications Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antipsychotic Medications Market Size by Type
7.1.1 Europe Antipsychotic Medications Sales by Type (2018-2034)
7.1.2 Europe Antipsychotic Medications Revenue by Type (2018-2034)
7.2 Europe Antipsychotic Medications Market Size by Application
7.2.1 Europe Antipsychotic Medications Sales by Application (2018-2034)
7.2.2 Europe Antipsychotic Medications Revenue by Application (2018-2034)
7.3 Europe Antipsychotic Medications Market Size by Country
7.3.1 Europe Antipsychotic Medications Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Antipsychotic Medications Sales by Country (2018-2034)
7.3.3 Europe Antipsychotic Medications Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antipsychotic Medications Market Size
8.1.1 China Antipsychotic Medications Sales (2018-2034)
8.1.2 China Antipsychotic Medications Revenue (2018-2034)
8.2 China Antipsychotic Medications Market Size by Application
8.2.1 China Antipsychotic Medications Sales by Application (2018-2034)
8.2.2 China Antipsychotic Medications Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Antipsychotic Medications Market Size by Type
9.1.1 Asia Antipsychotic Medications Sales by Type (2018-2034)
9.1.2 Asia Antipsychotic Medications Revenue by Type (2018-2034)
9.2 Asia Antipsychotic Medications Market Size by Application
9.2.1 Asia Antipsychotic Medications Sales by Application (2018-2034)
9.2.2 Asia Antipsychotic Medications Revenue by Application (2018-2034)
9.3 Asia Antipsychotic Medications Sales by Region
9.3.1 Asia Antipsychotic Medications Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Antipsychotic Medications Revenue by Region (2018-2034)
9.3.3 Asia Antipsychotic Medications Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antipsychotic Medications Market Size by Type
10.1.1 Middle East, Africa and Latin America Antipsychotic Medications Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Antipsychotic Medications Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Antipsychotic Medications Market Size by Application
10.2.1 Middle East, Africa and Latin America Antipsychotic Medications Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Antipsychotic Medications Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Antipsychotic Medications Sales by Country
10.3.1 Middle East, Africa and Latin America Antipsychotic Medications Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Antipsychotic Medications Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Antipsychotic Medications Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Information
11.1.2 Johnson and Johnson Overview
11.1.3 Johnson and Johnson Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Johnson and Johnson Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson and Johnson Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Overview
11.2.3 Eli Lilly Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Eli Lilly Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bristol-Myers Squibb Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 AstraZeneca Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Allergan
11.6.1 Allergan Company Information
11.6.2 Allergan Overview
11.6.3 Allergan Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Allergan Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allergan Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Pfizer Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Antipsychotic Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 GlaxoSmithKline Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antipsychotic Medications Industry Chain Analysis
12.2 Antipsychotic Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antipsychotic Medications Production Mode & Process
12.4 Antipsychotic Medications Sales and Marketing
12.4.1 Antipsychotic Medications Sales Channels
12.4.2 Antipsychotic Medications Distributors
12.5 Antipsychotic Medications Customers
13 Market Dynamics
13.1 Antipsychotic Medications Industry Trends
13.2 Antipsychotic Medications Market Drivers
13.3 Antipsychotic Medications Market Challenges
13.4 Antipsychotic Medications Market Restraints
14 Key Findings in The Global Antipsychotic Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antipsychotic Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Selective Serotonin Reuptake Inhibitors (SSRIs)
Table 3. Major Manufacturers of Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Table 4. Major Manufacturers of Tricyclic Antidepressants (TCAs)
Table 5. Major Manufacturers of Monoamine Oxidase Inhibitors (MAOIs)
Table 6. Major Manufacturers of Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
Table 7. Major Manufacturers of Tetracyclic Antidepressants (TeCAs)
Table 8. Major Manufacturers of Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
Table 9. Global Antipsychotic Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Antipsychotic Medications Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Antipsychotic Medications Revenue by Region (2018-2024) & (US$ Million)
Table 12. Global Antipsychotic Medications Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Antipsychotic Medications Revenue Market Share by Region (2018-2024)
Table 14. Global Antipsychotic Medications Revenue Market Share by Region (2024-2034)
Table 15. Global Antipsychotic Medications Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 16. Global Antipsychotic Medications Sales by Region (2018-2024) & (K Units)
Table 17. Global Antipsychotic Medications Sales by Region (2024-2034) & (K Units)
Table 18. Global Antipsychotic Medications Sales Market Share by Region (2018-2024)
Table 19. Global Antipsychotic Medications Sales Market Share by Region (2024-2034)
Table 20. Global Antipsychotic Medications Sales by Manufacturers (2018-2024) & (K Units)
Table 21. Global Antipsychotic Medications Sales Share by Manufacturers (2018-2024)
Table 22. Global Antipsychotic Medications Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 23. Global Antipsychotic Medications Revenue Share by Manufacturers (2018-2024)
Table 24. Global Key Players of Antipsychotic Medications, Industry Ranking, 2021 VS 2022 VS 2024
Table 25. Antipsychotic Medications Price by Manufacturers 2018-2024 (USD/Unit)
Table 26. Global Antipsychotic Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Antipsychotic Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medications as of 2022)
Table 28. Global Key Manufacturers of Antipsychotic Medications, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Antipsychotic Medications, Product Offered and Application
Table 30. Global Key Manufacturers of Antipsychotic Medications, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antipsychotic Medications Sales by Type (2018-2024) & (K Units)
Table 33. Global Antipsychotic Medications Sales by Type (2024-2034) & (K Units)
Table 34. Global Antipsychotic Medications Sales Share by Type (2018-2024)
Table 35. Global Antipsychotic Medications Sales Share by Type (2024-2034)
Table 36. Global Antipsychotic Medications Revenue by Type (2018-2024) & (US$ Million)
Table 37. Global Antipsychotic Medications Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global Antipsychotic Medications Revenue Share by Type (2018-2024)
Table 39. Global Antipsychotic Medications Revenue Share by Type (2024-2034)
Table 40. Antipsychotic Medications Price by Type (2018-2024) & (USD/Unit)
Table 41. Global Antipsychotic Medications Price Forecast by Type (2024-2034) & (USD/Unit)
Table 42. Global Antipsychotic Medications Sales by Application (2018-2024) & (K Units)
Table 43. Global Antipsychotic Medications Sales by Application (2024-2034) & (K Units)
Table 44. Global Antipsychotic Medications Sales Share by Application (2018-2024)
Table 45. Global Antipsychotic Medications Sales Share by Application (2024-2034)
Table 46. Global Antipsychotic Medications Revenue by Application (2018-2024) & (US$ Million)
Table 47. Global Antipsychotic Medications Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global Antipsychotic Medications Revenue Share by Application (2018-2024)
Table 49. Global Antipsychotic Medications Revenue Share by Application (2024-2034)
Table 50. Antipsychotic Medications Price by Application (2018-2024) & (USD/Unit)
Table 51. Global Antipsychotic Medications Price Forecast by Application (2024-2034) & (USD/Unit)
Table 52. US & Canada Antipsychotic Medications Sales by Type (2018-2024) & (K Units)
Table 53. US & Canada Antipsychotic Medications Sales by Type (2024-2034) & (K Units)
Table 54. US & Canada Antipsychotic Medications Revenue by Type (2018-2024) & (US$ Million)
Table 55. US & Canada Antipsychotic Medications Revenue by Type (2024-2034) & (US$ Million)
Table 56. US & Canada Antipsychotic Medications Sales by Application (2018-2024) & (K Units)
Table 57. US & Canada Antipsychotic Medications Sales by Application (2024-2034) & (K Units)
Table 58. US & Canada Antipsychotic Medications Revenue by Application (2018-2024) & (US$ Million)
Table 59. US & Canada Antipsychotic Medications Revenue by Application (2024-2034) & (US$ Million)
Table 60. US & Canada Antipsychotic Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. US & Canada Antipsychotic Medications Revenue by Country (2018-2024) & (US$ Million)
Table 62. US & Canada Antipsychotic Medications Revenue by Country (2024-2034) & (US$ Million)
Table 63. US & Canada Antipsychotic Medications Sales by Country (2018-2024) & (K Units)
Table 64. US & Canada Antipsychotic Medications Sales by Country (2024-2034) & (K Units)
Table 65. Europe Antipsychotic Medications Sales by Type (2018-2024) & (K Units)
Table 66. Europe Antipsychotic Medications Sales by Type (2024-2034) & (K Units)
Table 67. Europe Antipsychotic Medications Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Antipsychotic Medications Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Antipsychotic Medications Sales by Application (2018-2024) & (K Units)
Table 70. Europe Antipsychotic Medications Sales by Application (2024-2034) & (K Units)
Table 71. Europe Antipsychotic Medications Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Antipsychotic Medications Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Antipsychotic Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Antipsychotic Medications Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Antipsychotic Medications Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Antipsychotic Medications Sales by Country (2018-2024) & (K Units)
Table 77. Europe Antipsychotic Medications Sales by Country (2024-2034) & (K Units)
Table 78. China Antipsychotic Medications Sales by Type (2018-2024) & (K Units)
Table 79. China Antipsychotic Medications Sales by Type (2024-2034) & (K Units)
Table 80. China Antipsychotic Medications Revenue by Type (2018-2024) & (US$ Million)
Table 81. China Antipsychotic Medications Revenue by Type (2024-2034) & (US$ Million)
Table 82. China Antipsychotic Medications Sales by Application (2018-2024) & (K Units)
Table 83. China Antipsychotic Medications Sales by Application (2024-2034) & (K Units)
Table 84. China Antipsychotic Medications Revenue by Application (2018-2024) & (US$ Million)
Table 85. China Antipsychotic Medications Revenue by Application (2024-2034) & (US$ Million)
Table 86. Asia Antipsychotic Medications Sales by Type (2018-2024) & (K Units)
Table 87. Asia Antipsychotic Medications Sales by Type (2024-2034) & (K Units)
Table 88. Asia Antipsychotic Medications Revenue by Type (2018-2024) & (US$ Million)
Table 89. Asia Antipsychotic Medications Revenue by Type (2024-2034) & (US$ Million)
Table 90. Asia Antipsychotic Medications Sales by Application (2018-2024) & (K Units)
Table 91. Asia Antipsychotic Medications Sales by Application (2024-2034) & (K Units)
Table 92. Asia Antipsychotic Medications Revenue by Application (2018-2024) & (US$ Million)
Table 93. Asia Antipsychotic Medications Revenue by Application (2024-2034) & (US$ Million)
Table 94. Asia Antipsychotic Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 95. Asia Antipsychotic Medications Revenue by Region (2018-2024) & (US$ Million)
Table 96. Asia Antipsychotic Medications Revenue by Region (2024-2034) & (US$ Million)
Table 97. Asia Antipsychotic Medications Sales by Region (2018-2024) & (K Units)
Table 98. Asia Antipsychotic Medications Sales by Region (2024-2034) & (K Units)
Table 99. Middle East, Africa and Latin America Antipsychotic Medications Sales by Type (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Antipsychotic Medications Sales by Type (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America Antipsychotic Medications Revenue by Type (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Antipsychotic Medications Revenue by Type (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America Antipsychotic Medications Sales by Application (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Antipsychotic Medications Sales by Application (2024-2034) & (K Units)
Table 105. Middle East, Africa and Latin America Antipsychotic Medications Revenue by Application (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antipsychotic Medications Revenue by Application (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America Antipsychotic Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 108. Middle East, Africa and Latin America Antipsychotic Medications Revenue by Country (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Antipsychotic Medications Revenue by Country (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Antipsychotic Medications Sales by Country (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Antipsychotic Medications Sales by Country (2024-2034) & (K Units)
Table 112. Johnson and Johnson Company Information
Table 113. Johnson and Johnson Description and Major Businesses
Table 114. Johnson and Johnson Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Johnson and Johnson Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Johnson and Johnson Recent Developments
Table 117. Eli Lilly Company Information
Table 118. Eli Lilly Description and Major Businesses
Table 119. Eli Lilly Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Eli Lilly Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Eli Lilly Recent Developments
Table 122. Bristol-Myers Squibb Company Information
Table 123. Bristol-Myers Squibb Description and Major Businesses
Table 124. Bristol-Myers Squibb Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Bristol-Myers Squibb Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bristol-Myers Squibb Recent Developments
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. AstraZeneca Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AstraZeneca Recent Developments
Table 132. Novartis Company Information
Table 133. Novartis Description and Major Businesses
Table 134. Novartis Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Novartis Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Novartis Recent Developments
Table 137. Allergan Company Information
Table 138. Allergan Description and Major Businesses
Table 139. Allergan Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Allergan Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Allergan Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Pfizer Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. GlaxoSmithKline Company Information
Table 148. GlaxoSmithKline Description and Major Businesses
Table 149. GlaxoSmithKline Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. GlaxoSmithKline Antipsychotic Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. GlaxoSmithKline Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Antipsychotic Medications Distributors List
Table 155. Antipsychotic Medications Customers List
Table 156. Antipsychotic Medications Market Trends
Table 157. Antipsychotic Medications Market Drivers
Table 158. Antipsychotic Medications Market Challenges
Table 159. Antipsychotic Medications Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Antipsychotic Medications Product Picture
Figure 2. Global Antipsychotic Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antipsychotic Medications Market Share by Type in 2022 & 2034
Figure 4. Selective Serotonin Reuptake Inhibitors (SSRIs) Product Picture
Figure 5. Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Product Picture
Figure 6. Tricyclic Antidepressants (TCAs) Product Picture
Figure 7. Monoamine Oxidase Inhibitors (MAOIs) Product Picture
Figure 8. Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Product Picture
Figure 9. Tetracyclic Antidepressants (TeCAs) Product Picture
Figure 10. Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Product Picture
Figure 11. Global Antipsychotic Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 12. Global Antipsychotic Medications Market Share by Application in 2022 & 2034
Figure 13. Hospital Pharmacies
Figure 14. Drug Stores
Figure 15. Others
Figure 16. Antipsychotic Medications Report Years Considered
Figure 17. Global Antipsychotic Medications Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Antipsychotic Medications Revenue 2018-2034 (US$ Million)
Figure 19. Global Antipsychotic Medications Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 20. Global Antipsychotic Medications Revenue Market Share by Region (2018-2034)
Figure 21. Global Antipsychotic Medications Sales 2018-2034 ((K Units)
Figure 22. Global Antipsychotic Medications Sales Market Share by Region (2018-2034)
Figure 23. US & Canada Antipsychotic Medications Sales YoY (2018-2034) & (K Units)
Figure 24. US & Canada Antipsychotic Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Antipsychotic Medications Sales YoY (2018-2034) & (K Units)
Figure 26. Europe Antipsychotic Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Antipsychotic Medications Sales YoY (2018-2034) & (K Units)
Figure 28. China Antipsychotic Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Asia (excluding China) Antipsychotic Medications Sales YoY (2018-2034) & (K Units)
Figure 30. Asia (excluding China) Antipsychotic Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Antipsychotic Medications Sales YoY (2018-2034) & (K Units)
Figure 32. Middle East, Africa and Latin America Antipsychotic Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Antipsychotic Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Antipsychotic Medications in the World: Market Share by Antipsychotic Medications Revenue in 2022
Figure 35. Global Antipsychotic Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Antipsychotic Medications Sales Market Share by Type (2018-2034)
Figure 37. Global Antipsychotic Medications Revenue Market Share by Type (2018-2034)
Figure 38. Global Antipsychotic Medications Sales Market Share by Application (2018-2034)
Figure 39. Global Antipsychotic Medications Revenue Market Share by Application (2018-2034)
Figure 40. US & Canada Antipsychotic Medications Sales Market Share by Type (2018-2034)
Figure 41. US & Canada Antipsychotic Medications Revenue Market Share by Type (2018-2034)
Figure 42. US & Canada Antipsychotic Medications Sales Market Share by Application (2018-2034)
Figure 43. US & Canada Antipsychotic Medications Revenue Market Share by Application (2018-2034)
Figure 44. US & Canada Antipsychotic Medications Revenue Share by Country (2018-2034)
Figure 45. US & Canada Antipsychotic Medications Sales Share by Country (2018-2034)
Figure 46. U.S. Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Antipsychotic Medications Sales Market Share by Type (2018-2034)
Figure 49. Europe Antipsychotic Medications Revenue Market Share by Type (2018-2034)
Figure 50. Europe Antipsychotic Medications Sales Market Share by Application (2018-2034)
Figure 51. Europe Antipsychotic Medications Revenue Market Share by Application (2018-2034)
Figure 52. Europe Antipsychotic Medications Revenue Share by Country (2018-2034)
Figure 53. Europe Antipsychotic Medications Sales Share by Country (2018-2034)
Figure 54. Germany Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 55. France Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 59. China Antipsychotic Medications Sales Market Share by Type (2018-2034)
Figure 60. China Antipsychotic Medications Revenue Market Share by Type (2018-2034)
Figure 61. China Antipsychotic Medications Sales Market Share by Application (2018-2034)
Figure 62. China Antipsychotic Medications Revenue Market Share by Application (2018-2034)
Figure 63. Asia Antipsychotic Medications Sales Market Share by Type (2018-2034)
Figure 64. Asia Antipsychotic Medications Revenue Market Share by Type (2018-2034)
Figure 65. Asia Antipsychotic Medications Sales Market Share by Application (2018-2034)
Figure 66. Asia Antipsychotic Medications Revenue Market Share by Application (2018-2034)
Figure 67. Asia Antipsychotic Medications Revenue Share by Region (2018-2034)
Figure 68. Asia Antipsychotic Medications Sales Share by Region (2018-2034)
Figure 69. Japan Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 70. South Korea Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 71. China Taiwan Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 72. Southeast Asia Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 73. India Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Antipsychotic Medications Sales Market Share by Type (2018-2034)
Figure 75. Middle East, Africa and Latin America Antipsychotic Medications Revenue Market Share by Type (2018-2034)
Figure 76. Middle East, Africa and Latin America Antipsychotic Medications Sales Market Share by Application (2018-2034)
Figure 77. Middle East, Africa and Latin America Antipsychotic Medications Revenue Market Share by Application (2018-2034)
Figure 78. Middle East, Africa and Latin America Antipsychotic Medications Revenue Share by Country (2018-2034)
Figure 79. Middle East, Africa and Latin America Antipsychotic Medications Sales Share by Country (2018-2034)
Figure 80. Brazil Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 81. Mexico Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 82. Turkey Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 83. Israel Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 84. GCC Countries Antipsychotic Medications Revenue (2018-2034) & (US$ Million)
Figure 85. Antipsychotic Medications Value Chain
Figure 86. Antipsychotic Medications Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries